Asia Pacific Allergy Diagnostics And Therapeutics Market Size & Outlook
Asia Pacific allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
Asia Pacific allergy diagnostics and therapeutics market highlights
- The Asia Pacific allergy diagnostics and therapeutics market generated a revenue of USD 5,688.2 million in 2023.
- The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 5,688.2 million |
| Market revenue in 2030 | USD 9,489.1 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.1% of the global allergy diagnostics and therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,489.1 million by 2030.
Inhaled was the largest segment with a revenue share of 54.86% in 2023. Horizon Databook has segmented the Asia Pacific allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific allergy diagnostics and therapeutics market is expected to grow at a lucrative rate owing to various factors, such as increasing healthcare reforms and expanding healthcare infrastructure. Other factors contributing to the market growth are growing population, rising incidence of allergies, and increasing number of local companies entering the market.
Asia Pacific, with Japan, China, and India being notable markets in this region, is projected to boost the market within the region. Key players in these countries are undertaking various strategic initiatives to increase their dominance in the market.
Moreover, growing incidence of allergies due to various environmental factors also positively impacts the market. Rising incidence of asthma, chronic cough, and food allergies, among others, is increasing the demand for novel drugs and diagnostic technology in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific allergy diagnostics and therapeutics market size, by country, 2018-2030 (US$M)
Asia Pacific Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
